Table of Content

1 Market Overview of Direct-to-consumer Disease Risk and Health Test
1.1 Direct-to-consumer Disease Risk and Health Test Market Overview
1.1.1 Direct-to-consumer Disease Risk and Health Test Product Scope
1.1.2 Direct-to-consumer Disease Risk and Health Test Market Status and Outlook
1.2 Global Direct-to-consumer Disease Risk and Health Test Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Direct-to-consumer Disease Risk and Health Test Market Size by Region (2024-2034)
1.4 Global Direct-to-consumer Disease Risk and Health Test Historic Market Size by Region (2024-2024)
1.5 Global Direct-to-consumer Disease Risk and Health Test Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034)
1.6.1 North America Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034)
1.6.2 Europe Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034)
1.6.3 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034)
1.6.4 Latin America Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034)
1.6.5 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034)
2 Direct-to-consumer Disease Risk and Health Test Market by Type
2.1 Introduction
2.1.1 Celiac Disease
2.1.2 Parkinson Disease
2.1.3 Alzheimer Disease
2.1.4 Other
2.2 Global Direct-to-consumer Disease Risk and Health Test Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Direct-to-consumer Disease Risk and Health Test Historic Market Size by Type (2024-2024)
2.2.2 Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Direct-to-consumer Disease Risk and Health Test Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Direct-to-consumer Disease Risk and Health Test Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Direct-to-consumer Disease Risk and Health Test Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue Breakdown by Type (2024-2034)
3 Direct-to-consumer Disease Risk and Health Test Market Overview by Application
3.1 Introduction
3.1.1 Online
3.1.2 Offline
3.2 Global Direct-to-consumer Disease Risk and Health Test Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Direct-to-consumer Disease Risk and Health Test Historic Market Size by Application (2024-2024)
3.2.2 Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Direct-to-consumer Disease Risk and Health Test Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Direct-to-consumer Disease Risk and Health Test Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Direct-to-consumer Disease Risk and Health Test Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue Breakdown by Application (2024-2034)
4 Direct-to-consumer Disease Risk and Health Test Competition Analysis by Players
4.1 Global Direct-to-consumer Disease Risk and Health Test Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Direct-to-consumer Disease Risk and Health Test as of 2022)
4.3 Date of Key Players Enter into Direct-to-consumer Disease Risk and Health Test Market
4.4 Global Top Players Direct-to-consumer Disease Risk and Health Test Headquarters and Area Served
4.5 Key Players Direct-to-consumer Disease Risk and Health Test Product Solution and Service
4.6 Competitive Status
4.6.1 Direct-to-consumer Disease Risk and Health Test Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 23andMe
5.1.1 23andMe Profile
5.1.2 23andMe Main Business
5.1.3 23andMe Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.1.4 23andMe Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.1.5 23andMe Recent Developments
5.2 MyHeritage
5.2.1 MyHeritage Profile
5.2.2 MyHeritage Main Business
5.2.3 MyHeritage Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.2.4 MyHeritage Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.2.5 MyHeritage Recent Developments
5.3 LabCorp
5.3.1 LabCorp Profile
5.3.2 LabCorp Main Business
5.3.3 LabCorp Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.3.4 LabCorp Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.3.5 Myriad Genetics Recent Developments
5.4 Myriad Genetics
5.4.1 Myriad Genetics Profile
5.4.2 Myriad Genetics Main Business
5.4.3 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.4.4 Myriad Genetics Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.4.5 Myriad Genetics Recent Developments
5.5 Ancestry.com
5.5.1 Ancestry.com Profile
5.5.2 Ancestry.com Main Business
5.5.3 Ancestry.com Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.5.4 Ancestry.com Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.5.5 Ancestry.com Recent Developments
5.6 Quest Diagnostics
5.6.1 Quest Diagnostics Profile
5.6.2 Quest Diagnostics Main Business
5.6.3 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.6.4 Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.6.5 Quest Diagnostics Recent Developments
5.7 Gene By Gene
5.7.1 Gene By Gene Profile
5.7.2 Gene By Gene Main Business
5.7.3 Gene By Gene Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.7.4 Gene By Gene Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.7.5 Gene By Gene Recent Developments
5.8 DNA Diagnostics Center
5.8.1 DNA Diagnostics Center Profile
5.8.2 DNA Diagnostics Center Main Business
5.8.3 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.8.4 DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.8.5 DNA Diagnostics Center Recent Developments
5.9 Invitae
5.9.1 Invitae Profile
5.9.2 Invitae Main Business
5.9.3 Invitae Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.9.4 Invitae Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.9.5 Invitae Recent Developments
5.10 IntelliGenetics
5.10.1 IntelliGenetics Profile
5.10.2 IntelliGenetics Main Business
5.10.3 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.10.4 IntelliGenetics Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.10.5 IntelliGenetics Recent Developments
5.11 Ambry Genetics
5.11.1 Ambry Genetics Profile
5.11.2 Ambry Genetics Main Business
5.11.3 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.11.4 Ambry Genetics Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.11.5 Ambry Genetics Recent Developments
5.12 Living DNA
5.12.1 Living DNA Profile
5.12.2 Living DNA Main Business
5.12.3 Living DNA Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.12.4 Living DNA Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.12.5 Living DNA Recent Developments
5.13 EasyDNA
5.13.1 EasyDNA Profile
5.13.2 EasyDNA Main Business
5.13.3 EasyDNA Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.13.4 EasyDNA Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.13.5 EasyDNA Recent Developments
5.14 Pathway Genomics
5.14.1 Pathway Genomics Profile
5.14.2 Pathway Genomics Main Business
5.14.3 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.14.4 Pathway Genomics Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.14.5 Pathway Genomics Recent Developments
5.15 Centrillion Technology
5.15.1 Centrillion Technology Profile
5.15.2 Centrillion Technology Main Business
5.15.3 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.15.4 Centrillion Technology Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.15.5 Centrillion Technology Recent Developments
5.16 Xcode
5.16.1 Xcode Profile
5.16.2 Xcode Main Business
5.16.3 Xcode Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.16.4 Xcode Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.16.5 Xcode Recent Developments
5.17 Color Genomics
5.17.1 Color Genomics Profile
5.17.2 Color Genomics Main Business
5.17.3 Color Genomics Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.17.4 Color Genomics Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.17.5 Color Genomics Recent Developments
5.18 Anglia DNA Services
5.18.1 Anglia DNA Services Profile
5.18.2 Anglia DNA Services Main Business
5.18.3 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.18.4 Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.18.5 Anglia DNA Services Recent Developments
5.19 African Ancestry
5.19.1 African Ancestry Profile
5.19.2 African Ancestry Main Business
5.19.3 African Ancestry Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.19.4 African Ancestry Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.19.5 African Ancestry Recent Developments
5.20 Canadian DNA Services
5.20.1 Canadian DNA Services Profile
5.20.2 Canadian DNA Services Main Business
5.20.3 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.20.4 Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.20.5 Canadian DNA Services Recent Developments
5.21 DNA Family Check
5.21.1 DNA Family Check Profile
5.21.2 DNA Family Check Main Business
5.21.3 DNA Family Check Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.21.4 DNA Family Check Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.21.5 DNA Family Check Recent Developments
5.22 Alpha Biolaboratories
5.22.1 Alpha Biolaboratories Profile
5.22.2 Alpha Biolaboratories Main Business
5.22.3 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.22.4 Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.22.5 Alpha Biolaboratories Recent Developments
5.23 Test Me DNA
5.23.1 Test Me DNA Profile
5.23.2 Test Me DNA Main Business
5.23.3 Test Me DNA Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.23.4 Test Me DNA Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.23.5 Test Me DNA Recent Developments
5.24 23 Mofang
5.24.1 23 Mofang Profile
5.24.2 23 Mofang Main Business
5.24.3 23 Mofang Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.24.4 23 Mofang Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.24.5 23 Mofang Recent Developments
5.25 Genetic Health
5.25.1 Genetic Health Profile
5.25.2 Genetic Health Main Business
5.25.3 Genetic Health Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.25.4 Genetic Health Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.25.5 Genetic Health Recent Developments
5.26 DNA Services of America
5.26.1 DNA Services of America Profile
5.26.2 DNA Services of America Main Business
5.26.3 DNA Services of America Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.26.4 DNA Services of America Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.26.5 DNA Services of America Recent Developments
5.27 Shuwen Health Sciences
5.27.1 Shuwen Health Sciences Profile
5.27.2 Shuwen Health Sciences Main Business
5.27.3 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.27.4 Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.27.5 Shuwen Health Sciences Recent Developments
5.28 Mapmygenome
5.28.1 Mapmygenome Profile
5.28.2 Mapmygenome Main Business
5.28.3 Mapmygenome Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.28.4 Mapmygenome Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.28.5 Mapmygenome Recent Developments
5.29 Full Genomes
5.29.1 Full Genomes Profile
5.29.2 Full Genomes Main Business
5.29.3 Full Genomes Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
5.29.4 Full Genomes Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) & (2024-2024)
5.29.5 Full Genomes Recent Developments
6 North America
6.1 North America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Direct-to-consumer Disease Risk and Health Test Market Dynamics
11.1 Direct-to-consumer Disease Risk and Health Test Industry Trends
11.2 Direct-to-consumer Disease Risk and Health Test Market Drivers
11.3 Direct-to-consumer Disease Risk and Health Test Market Challenges
11.4 Direct-to-consumer Disease Risk and Health Test Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Direct-to-consumer Disease Risk and Health Test Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Direct-to-consumer Disease Risk and Health Test Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Direct-to-consumer Disease Risk and Health Test Market Size Share by Region (2024-2024)
Table 4. Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Direct-to-consumer Disease Risk and Health Test Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Direct-to-consumer Disease Risk and Health Test Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2024-2024)
Table 9. Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2024-2034)
Table 11. North America Direct-to-consumer Disease Risk and Health Test Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Direct-to-consumer Disease Risk and Health Test Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Direct-to-consumer Disease Risk and Health Test Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Direct-to-consumer Disease Risk and Health Test Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Direct-to-consumer Disease Risk and Health Test Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Direct-to-consumer Disease Risk and Health Test Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Direct-to-consumer Disease Risk and Health Test Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Direct-to-consumer Disease Risk and Health Test Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Application (2024-2024)
Table 24. Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Application (2024-2034)
Table 26. North America Direct-to-consumer Disease Risk and Health Test Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Direct-to-consumer Disease Risk and Health Test Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Direct-to-consumer Disease Risk and Health Test Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Direct-to-consumer Disease Risk and Health Test Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Direct-to-consumer Disease Risk and Health Test Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Direct-to-consumer Disease Risk and Health Test Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Direct-to-consumer Disease Risk and Health Test Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Direct-to-consumer Disease Risk and Health Test as of 2022)
Table 39. Date of Key Players Enter into Direct-to-consumer Disease Risk and Health Test Market
Table 40. Global Direct-to-consumer Disease Risk and Health Test Key Players Headquarters and Area Served
Table 41. Direct-to-consumer Disease Risk and Health Test Product Solution and Service
Table 42. Global Direct-to-consumer Disease Risk and Health Test Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. 23andMe Basic Information List
Table 45. 23andMe Description and Business Overview
Table 46. 23andMe Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 47. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of 23andMe (2024-2024)
Table 48. 23andMe Recent Developments
Table 49. MyHeritage Basic Information List
Table 50. MyHeritage Description and Business Overview
Table 51. MyHeritage Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 52. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of MyHeritage (2024-2024)
Table 53. MyHeritage Recent Developments
Table 54. LabCorp Basic Information List
Table 55. LabCorp Description and Business Overview
Table 56. LabCorp Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 57. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of LabCorp (2024-2024)
Table 58. LabCorp Recent Developments
Table 59. Myriad Genetics Basic Information List
Table 60. Myriad Genetics Description and Business Overview
Table 61. Myriad Genetics Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 62. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Myriad Genetics (2024-2024)
Table 63. Myriad Genetics Recent Developments
Table 64. Ancestry.com Basic Information List
Table 65. Ancestry.com Description and Business Overview
Table 66. Ancestry.com Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 67. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Ancestry.com (2024-2024)
Table 68. Ancestry.com Recent Developments
Table 69. Quest Diagnostics Basic Information List
Table 70. Quest Diagnostics Description and Business Overview
Table 71. Quest Diagnostics Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 72. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Quest Diagnostics (2024-2024)
Table 73. Quest Diagnostics Recent Developments
Table 74. Gene By Gene Basic Information List
Table 75. Gene By Gene Description and Business Overview
Table 76. Gene By Gene Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 77. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Gene By Gene (2024-2024)
Table 78. Gene By Gene Recent Developments
Table 79. DNA Diagnostics Center Basic Information List
Table 80. DNA Diagnostics Center Description and Business Overview
Table 81. DNA Diagnostics Center Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 82. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of DNA Diagnostics Center (2024-2024)
Table 83. DNA Diagnostics Center Recent Developments
Table 84. Invitae Basic Information List
Table 85. Invitae Description and Business Overview
Table 86. Invitae Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 87. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Invitae (2024-2024)
Table 88. Invitae Recent Developments
Table 89. IntelliGenetics Basic Information List
Table 90. IntelliGenetics Description and Business Overview
Table 91. IntelliGenetics Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 92. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of IntelliGenetics (2024-2024)
Table 93. IntelliGenetics Recent Developments
Table 94. Ambry Genetics Basic Information List
Table 95. Ambry Genetics Description and Business Overview
Table 96. Ambry Genetics Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 97. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Ambry Genetics (2024-2024)
Table 98. Ambry Genetics Recent Developments
Table 99. Living DNA Basic Information List
Table 100. Living DNA Description and Business Overview
Table 101. Living DNA Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 102. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Living DNA (2024-2024)
Table 103. Living DNA Recent Developments
Table 104. EasyDNA Basic Information List
Table 105. EasyDNA Description and Business Overview
Table 106. EasyDNA Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 107. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of EasyDNA (2024-2024)
Table 108. EasyDNA Recent Developments
Table 109. Pathway Genomics Basic Information List
Table 110. Pathway Genomics Description and Business Overview
Table 111. Pathway Genomics Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 112. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Pathway Genomics (2024-2024)
Table 113. Pathway Genomics Recent Developments
Table 114. Centrillion Technology Basic Information List
Table 115. Centrillion Technology Description and Business Overview
Table 116. Centrillion Technology Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 117. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Centrillion Technology (2024-2024)
Table 118. Centrillion Technology Recent Developments
Table 119. Xcode Basic Information List
Table 120. Xcode Description and Business Overview
Table 121. Xcode Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 122. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Xcode (2024-2024)
Table 123. Xcode Recent Developments
Table 124. Color Genomics Basic Information List
Table 125. Color Genomics Description and Business Overview
Table 126. Color Genomics Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 127. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Color Genomics (2024-2024)
Table 128. Color Genomics Recent Developments
Table 129. Anglia DNA Services Basic Information List
Table 130. Anglia DNA Services Description and Business Overview
Table 131. Anglia DNA Services Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 132. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Anglia DNA Services (2024-2024)
Table 133. Anglia DNA Services Recent Developments
Table 134. African Ancestry Basic Information List
Table 135. African Ancestry Description and Business Overview
Table 136. African Ancestry Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 137. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of African Ancestry (2024-2024)
Table 138. African Ancestry Recent Developments
Table 139. Canadian DNA Services Basic Information List
Table 140. Canadian DNA Services Description and Business Overview
Table 141. Canadian DNA Services Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 142. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Canadian DNA Services (2024-2024)
Table 143. Canadian DNA Services Recent Developments
Table 144. DNA Family Check Basic Information List
Table 145. DNA Family Check Description and Business Overview
Table 146. DNA Family Check Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 147. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of DNA Family Check (2024-2024)
Table 148. DNA Family Check Recent Developments
Table 149. Alpha Biolaboratories Basic Information List
Table 150. Alpha Biolaboratories Description and Business Overview
Table 151. Alpha Biolaboratories Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 152. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Alpha Biolaboratories (2024-2024)
Table 153. Alpha Biolaboratories Recent Developments
Table 154. Test Me DNA Basic Information List
Table 155. Test Me DNA Description and Business Overview
Table 156. Test Me DNA Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 157. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Test Me DNA (2024-2024)
Table 158. Test Me DNA Recent Developments
Table 159. 23 Mofang Basic Information List
Table 160. 23 Mofang Description and Business Overview
Table 161. 23 Mofang Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 162. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of 23 Mofang (2024-2024)
Table 163. 23 Mofang Recent Developments
Table 164. Genetic Health Basic Information List
Table 165. Genetic Health Description and Business Overview
Table 166. Genetic Health Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 167. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Genetic Health (2024-2024)
Table 168. Genetic Health Recent Developments
Table 169. DNA Services of America Basic Information List
Table 170. DNA Services of America Description and Business Overview
Table 171. DNA Services of America Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 172. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of DNA Services of America (2024-2024)
Table 173. DNA Services of America Recent Developments
Table 174. Shuwen Health Sciences Basic Information List
Table 175. Shuwen Health Sciences Description and Business Overview
Table 176. Shuwen Health Sciences Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 177. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Shuwen Health Sciences (2024-2024)
Table 178. Shuwen Health Sciences Recent Developments
Table 179. Mapmygenome Basic Information List
Table 180. Mapmygenome Description and Business Overview
Table 181. Mapmygenome Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 182. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Mapmygenome (2024-2024)
Table 183. Mapmygenome Recent Developments
Table 184. Full Genomes Basic Information List
Table 185. Full Genomes Description and Business Overview
Table 186. Full Genomes Direct-to-consumer Disease Risk and Health Test Products, Services and Solutions
Table 187. Revenue (US$ Million) in Direct-to-consumer Disease Risk and Health Test Business of Full Genomes (2024-2024)
Table 188. Full Genomes Recent Developments
Table 189. North America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2024-2024) & (US$ Million)
Table 190. North America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2024-2034) & (US$ Million)
Table 191. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country (2024-2024) & (US$ Million)
Table 192. Europe Direct-to-consumer Disease Risk and Health Test Market Size by Country (2024-2034) & (US$ Million)
Table 193. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 194. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Region (2024-2024) & (US$ Million)
Table 195. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size by Region (2024-2034) & (US$ Million)
Table 196. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Share by Region (2024-2024)
Table 197. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Share by Region (2024-2034)
Table 198. Latin America Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 199. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2024-2024) & (US$ Million)
Table 200. Latin America Direct-to-consumer Disease Risk and Health Test Market Size by Country (2024-2034) & (US$ Million)
Table 201. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 202. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country (2024-2024) & (US$ Million)
Table 203. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size by Country (2024-2034) & (US$ Million)
Table 204. Direct-to-consumer Disease Risk and Health Test Market Trends
Table 205. Direct-to-consumer Disease Risk and Health Test Market Drivers
Table 206. Direct-to-consumer Disease Risk and Health Test Market Challenges
Table 207. Direct-to-consumer Disease Risk and Health Test Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Direct-to-consumer Disease Risk and Health Test Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Direct-to-consumer Disease Risk and Health Test Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Direct-to-consumer Disease Risk and Health Test Market Share by Regions: 2022 VS 2034
Figure 4. Global Direct-to-consumer Disease Risk and Health Test Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Celiac Disease
Figure 11. Global Celiac Disease Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Parkinson Disease
Figure 13. Global Parkinson Disease Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Alzheimer Disease
Figure 15. Global Alzheimer Disease Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Other
Figure 17. Global Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Global Direct-to-consumer Disease Risk and Health Test Market Size Share by Type: 2022 & 2034
Figure 19. North America Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2024-2034)
Figure 20. Europe Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2024-2034)
Figure 21. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2024-2034)
Figure 22. Latin America Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2024-2034)
Figure 23. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Type (2024-2034)
Figure 24. Online Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Offline Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Global Direct-to-consumer Disease Risk and Health Test Market Size Share by Application: 2022 & 2034
Figure 27. North America Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Application (2024-2034)
Figure 28. Europe Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Application (2024-2034)
Figure 29. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Application (2024-2034)
Figure 30. Latin America Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Application (2024-2034)
Figure 31. Middle East and Africa Direct-to-consumer Disease Risk and Health Test Revenue Market Share by Application (2024-2034)
Figure 32. Direct-to-consumer Disease Risk and Health Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 33. Global Top 5 and Top 10 Players Direct-to-consumer Disease Risk and Health Test Market Share in 2022
Figure 34. North America Direct-to-consumer Disease Risk and Health Test Market Share by Country (2024-2034)
Figure 35. U.S. Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 36. Canada Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 37. Germany Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 38. France Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 39. U.K. Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 40. Italy Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 41. Russia Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 42. Nordic Countries Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 43. Asia-Pacific Direct-to-consumer Disease Risk and Health Test Market Share by Region (2024-2034)
Figure 44. China Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 45. Japan Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 46. South Korea Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 47. Southeast Asia Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 48. India Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 49. Australia Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 50. Latin America Direct-to-consumer Disease Risk and Health Test Market Share by Country (2024-2034)
Figure 51. Mexico Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 52. Brazil Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 53. Middle East & Africa Direct-to-consumer Disease Risk and Health Test Market Share by Country (2024-2034)
Figure 54. Turkey Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 55. Saudi Arabia Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 56. UAE Direct-to-consumer Disease Risk and Health Test Market Size (2024-2034) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report